Table 1. Peptides selected for screening against NP cells.
Peptide Name | Amino Acid Sequence | Reported Cell Receptors |
---|---|---|
GD6 | CGG(KQNCLSSRAS)FRGCVRNLRLSR | Integrin α3 [32,35,40,44,45] |
P4 | CGGPPFLMLLKGSTR | Integrin α3 [32,35,44,45,71] |
p678 | CGGFQGVLQNVRFVF | Integrin α3 [32,34,35,44,45,71] |
cNGQ | CGGcMGQGEQc (cyclic) | Integrin α3 [32,35,44,45] |
AG32 | CGGTWYKIAFQRNRK | Integrins α2, α6, β1 [27, 29,38] |
AG10 | CGGNRWHSIYITRFG | Integrins α2, α5, α6, β1 [27,29,38] |
T1 | CGGTTSWSQCSKS | Integrin α6 [31,46,47] |
AG73 | CGGRKRLQVQLSIRT | Syndecans [25,27,37,49,53-56,72] |
RGD | CGGRGDS | Integrins α5, αV, α8 [15-18,50,51] |
IKVAV | CSRARKQAASIKVAVSADR | Integrins [33,39,48,49] |
Table 1. Laminin-mimetic peptides used for initial screening.